Obesity Drug Coverage Restrictions Impact Millions of Patients

Millions of patients have lost coverage for popular obesity drugs like Zepbound and Wegovy over the past year due to new restrictions, forcing many to seek alternative treatments.

22 Apr, 13:25 — 22 Apr, 13:25

Post Share

Sources

Showing 1 of 1 sources

NPRHigh110d ago

Restrictions on obesity drug coverage force patients to pivot

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.

By Sydney Lupkin

Read full article →

PERSPECTA

PERSPECTA

Obesity Drug Coverage Restrictions Impact Millions of Patients

Sources

Restrictions on obesity drug coverage force patients to pivot

Related Stories

Ukrainian MiG-29 Fighter Jet Crashes in Odesa Region

Teenager Injured in Car Crash and Fall into Ravine in Arta

Russia Bars Only Anti-War Party From Parliamentary Elections

Rare supercar seized in London, police officer enjoys driving it to depot

PERSPECTA